Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

NCT02467504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: hrIL-2 active
DRUG: hrIL-2 placebo
DRUG: MTX
DRUG: Folic Acid
DRUG: Loxoprofen

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]